<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04167592</url>
  </required_header>
  <id_info>
    <org_study_id>IndonesiaUAnes041</org_study_id>
    <nct_id>NCT04167592</nct_id>
  </id_info>
  <brief_title>Benzydamine Hydrochloride Gargle in Reducing Propofol for ERCP</brief_title>
  <acronym>ERCP</acronym>
  <official_title>Effectivity of Benzydamine Hydrochloride Gargle to Reduce Propofol Consumption in Endoscopic Retrograde Cholangiopancreatography Procedure</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Indonesia University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Indonesia University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      It was a study aimed to determine the effectivity of benzydamine hydrochloride gargling in
      reducing propofol consumption in the Endoscopic Retrograde Cholangiopancreatography (ERCP)
      procedure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study was approved by Ethics Committee of Indonesia University. It was a single-blind
      randomized clinical trial at Cipto Mangunkusumo Hospital - Jakarta during August to September
      2018. 72 subjects were recruited and randomly assigned into 2 groups. Patients in group B
      were given 0.15% mouthwash with benzydamine hydrochloride prior to procedure while patients
      in group C were given mouthwash with 15 ml of water. Cumulative propofol consumption per
      minute per kg body weight, and incidence of postoperative sore throat were measured for each
      group.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2018</start_date>
  <completion_date type="Actual">October 1, 2018</completion_date>
  <primary_completion_date type="Actual">September 1, 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cumulative Propofol Consumption</measure>
    <time_frame>90 minutes</time_frame>
    <description>About 1 mg/kg Propofol was initially administered to sedate the subjects. If the subject's RSS (Ramsay Sedation Scale) rose, 0.3 mg/kg was additionally given. The amount of propofol used, as in mg/kg, during the ERCP procedure was recorded.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Incidence of Sore Throat</measure>
    <time_frame>4 hours</time_frame>
    <description>Sore throat incidence after ERCP procedure was recorded</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">72</enrollment>
  <condition>ERCP</condition>
  <arm_group>
    <arm_group_label>Benzydamine Hydrochloride Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects who were allocated in benzydamine group would gargle with 15 of ml benzydamine hydrochloride 0.15% before sedation started.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Subjects who were allocated in control group would gargle with 15 ml of water before sedation started.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Benzydamine Hydrochloride 0.15% Oral Rinse</intervention_name>
    <description>Benzydamine Hydrochloride 0.15% Oral Rinse was used to gargle prior to Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.</description>
    <arm_group_label>Benzydamine Hydrochloride Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Water</intervention_name>
    <description>Water was used to gargle prior to Endoscopic Retrograde Cholangiopancreatography (ERCP) procedure.</description>
    <arm_group_label>Control Group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  undergoing ERCP

          -  ASA I-III

          -  BMI 18-30 kg/m2

        Exclusion Criteria:

          -  allergic to propofol

          -  contraindicated to propofol

          -  had throat wound or laceration

          -  received analgesics or steroid in 24 hours priorly

          -  unstable during sedation

          -  procedure longer than 90 minutes
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adhrie Sugiarto, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Indonesia University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cipto Mangunkusumo General Hospital</name>
      <address>
        <city>Jakarta Pusat</city>
        <state>DKI Jakarta</state>
        <zip>10430</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <reference>
    <citation>Triantafillidis JK, Merikas E, Nikolakis D, Papalois AE. Sedation in gastrointestinal endoscopy: current issues. World J Gastroenterol. 2013 Jan 28;19(4):463-81. doi: 10.3748/wjg.v19.i4.463. Review.</citation>
    <PMID>23382625</PMID>
  </reference>
  <reference>
    <citation>Yang JF, Farooq P, Zwilling K, Patel D, Siddiqui AA. Efficacy and Safety of Propofol-Mediated Sedation for Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP). Dig Dis Sci. 2016 Jun;61(6):1686-91. doi: 10.1007/s10620-016-4043-3. Epub 2016 Jan 29. Erratum in: Dig Dis Sci. 2016 Jul;61(7):2146.</citation>
    <PMID>26825844</PMID>
  </reference>
  <reference>
    <citation>Kati I, Tekin M, Silay E, Huseyinoglu UA, Yildiz H. Does benzydamine hydrochloride applied preemptively reduce sore throat due to laryngeal mask airway? Anesth Analg. 2004 Sep;99(3):710-2, table of contents.</citation>
    <PMID>15333399</PMID>
  </reference>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 8, 2019</study_first_submitted>
  <study_first_submitted_qc>November 15, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2019</study_first_posted>
  <last_update_submitted>November 15, 2019</last_update_submitted>
  <last_update_submitted_qc>November 15, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 19, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Indonesia University</investigator_affiliation>
    <investigator_full_name>Adhrie Sugiarto</investigator_full_name>
    <investigator_title>Medical Staff</investigator_title>
  </responsible_party>
  <keyword>propofol</keyword>
  <keyword>benzydamine hydrochloride</keyword>
  <keyword>sore throat</keyword>
  <keyword>Endoscopic Retrograde Cholangiopancreatography</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Benzydamine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

